86 related articles for article (PubMed ID: 23785049)
1. Personalized medicine: through the looking glass of functional imaging.
Hohl RJ
Clin Cancer Res; 2013 Aug; 19(15):4024-6. PubMed ID: 23785049
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of PET-CT data for radiotherapy planning: what are we looking for?
Chiti A; Kirienko M; Grégoire V
Radiother Oncol; 2010 Sep; 96(3):277-9. PubMed ID: 20727607
[No Abstract] [Full Text] [Related]
4. Personalized medicine in oncology: where have we come from and where are we going?
André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
Vaiopoulou A; Gazouli M; Karikas GA
J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
[TBL] [Abstract][Full Text] [Related]
6. [Personalized treatment of cancer: utopia or chance?].
Thiel E
Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
[No Abstract] [Full Text] [Related]
7. Molecular imaging in the framework of personalized cancer medicine.
Belkić D; Belkić K
Isr Med Assoc J; 2013 Nov; 15(11):665-72. PubMed ID: 24511645
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine in psychiatry: new technologies and approaches.
Costa e Silva JA
Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
[TBL] [Abstract][Full Text] [Related]
9. [Medical imaging analysis of tumor heterogeneity and their clinical application].
Dong XZ; Xing LG; Yu JM
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):81-4. PubMed ID: 23714658
[No Abstract] [Full Text] [Related]
10. PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET.
Slobbe P; Poot AJ; Windhorst AD; van Dongen GA
Drug Discov Today; 2012 Nov; 17(21-22):1175-87. PubMed ID: 22766374
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics and personalised medicine: maintain a critical approach.
Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
[TBL] [Abstract][Full Text] [Related]
12. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
Alberti C
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of treatment results with biological agents: is there a need for a new methodology?
Begent RH
J BUON; 2007 Sep; 12 Suppl 1():S53-8. PubMed ID: 17935278
[TBL] [Abstract][Full Text] [Related]
14. Systems medicine: a real approach for future personalized oncology?
Roukos DH
Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
[No Abstract] [Full Text] [Related]
15. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
[TBL] [Abstract][Full Text] [Related]
16. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice on the horizon: personalized medicine.
Chadwell K
Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
[TBL] [Abstract][Full Text] [Related]
18. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos M; Vielh P; Soria JC; Andre F
J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
[TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacogenomics: do cancer cell lines have the right stuff?
Auman JT
Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522
[No Abstract] [Full Text] [Related]
20. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
